SCHEMBL25901380

SCHEMBL25901380

CCOC(=O)[C@H]1OC1C(=O)NC(CC(C)C)C(=O)NCCC(F)(F)F

nearest known ligand 0.76

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CAPN1 P07384 14/20 0.76
▸ CTSL P07711 3/20 0.76
▸ CTSB P07858 3/20 0.76
▸ LMNA P02545 2/20 0.76
▸ CTSG P08311 1/20 0.76
▸ CAPN9 O14815 3/20 0.54
▸ MAPK1 P28482 2/20 0.54
▸ CTSK P43235 2/20 0.46
▸ CTSH P09668 1/20 0.46
▸ CTSS P25774 1/20 0.46
▸ CTSC P53634 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ USP2 O75604 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ BLM P54132 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31406918 1.00 CAPN1 (0.76) CAPN1CTSLCTSBLMNACTSG
SCHEMBL12653863 0.89 CAPN1 (0.76) CAPN1CTSLCTSBLMNACTSG
SCHEMBL20381489 0.88 CAPN1 (0.74) CAPN1CTSLCTSBLMNACTSG
SCHEMBL16329166 0.87 CAPN1 (0.73) CAPN1CTSLCTSBLMNACTSG
Aloxistatin SCHEMBL12620387 0.86 CAPN1 (1.00) CAPN1CTSLCTSBLMNACTSG
Aloxistatin SCHEMBL18498407 0.86 CAPN1 (1.00) CAPN1CTSLCTSBLMNACTSG
Aloxistatin SCHEMBL254426 0.86 CAPN1 (1.00) CAPN1CTSLCTSBLMNACTSG
Aloxistatin SCHEMBL21981208 0.86 CAPN1 (1.00) CAPN1CTSLCTSBLMNACTSG
Aloxistatin SCHEMBL21981210 0.86 CAPN1 (1.00) CAPN1CTSLCTSBLMNACTSG
Aloxistatin SCHEMBL483320 0.86 CAPN1 (1.00) CAPN1CTSLCTSBLMNACTSG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023135480-A1 COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH IMPAIRED β-GALACTOSIDASE ACTIVITY DORPHAN SA (CH) 2023-07-20 — — WO disclosed
Send feedback